Boston Scientific (NYSE:BSX) won the 1st personal injury lawsuit to go to trial over its Pinnacle pelvic mesh product, after a Massachusetts jury yesterday found that the device was properly designed and that the medical device company gave adequate warning about risks, according to Bloomberg.
Diane Albright alleged that the Pinnacle mesh was improperly designed and caused her injuries after it was implanted in 2010, according to the news service.
It was the 1st case of some 12,000 Boston Scientific is facing over its vaginal mesh devices. The Marlborough, Mass.-based company and peers C.R. Bard (NYSE:BCR), Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon, Endo Health Solutions (NSDQ:ENDP), Cook Medical, Covidien (NYSE:COV) and Coloplast (CPH:COLO B) are facing a raft of lawsuits over their respective pelvic mesh offerings.
Boston Scientific spokeswoman Denise Kaigler told Bloomberg that the company is "pleased" with the outcome of Albright v. Boston Scientific Corp., which was tried in the Middlesex County Superior Court in Woburn, Mass.
"Patient safety is of utmost importance to Boston Scientific and we dedicate significant resources to deliver safe, high-quality products," Kaigler said via email to the news service.
One of Albright’s attorney’s, Fred Thompson, said jurors in Woburn deliberated for more than 6 hours over 2 days before returning the verdict. Boston Scientific’s next pelvic mesh trial is slated to go to trial in September in state court in Wilmington, Del., Thompson said.